PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

IOM report details strategy for monitoring safety of childhood immunization schedule

2013-01-16
(Press-News.org) WASHINGTON -- A review of the available evidence underscores the safety of the federal childhood immunization schedule, says a new report from the Institute of Medicine. Should signals indicate the need for investigation of the schedule, however, the report offers a framework for conducting safety research using existing or new data collection systems.

Roughly 90 percent of American children receive most childhood vaccines advised by the federal immunization schedule by the time they enter kindergarten, noted the committee that wrote the report. However, some parents choose to spread out their children's immunizations over a different time frame than recommended by the schedule and a small fraction object to having their children immunized at all. Their concerns arise in part from the number of doses that children receive; the schedule entails 24 immunizations by age 2 given in amounts ranging from one to five injections during a pediatric visit. Some critics of immunization policies have called for studies comparing health outcomes among vaccinated and unvaccinated children and for research to determine if subgroups exist that are predisposed to experiencing harmful health effects from the vaccines.

Studies have repeatedly shown the health benefits associated with the recommended schedule, including fewer illnesses, deaths, and hospital stays, the report notes. Every new vaccine is tested for safety and evaluated in the context of the entire schedule before it is added. And the systems designed to detect possible harmful effects of immunization have worked well at discovering occasional problems with individual vaccines, such as a rare intestinal disorder linked to a now-discontinued rotavirus vaccine. However, the elements of the schedule -- the number, frequency, timing, order, and age at which vaccines are given -- are not well-defined in existing research and should be improved.

Until newer and bigger data collection systems can be harnessed, the Vaccine Safety Datalink (VSD) is the best available tool for exploring questions about the immunization schedule should the need arise, the committee concluded. This database contains information on the immunization histories of more than 9 million people covered by nine participating managed care organizations. Researchers can identify individuals who were vaccinated according to alternative schedules as well as any diagnoses, medical procedures, and outcomes they have experienced. VSD also contains data on race, age, gender, and other factors that help researchers do better comparisons and account for factors that might affect participants' health. Already a research team has tapped VSD to explore patterns among children in the Kaiser Permanente Colorado system who are defined as undervaccinated.

However, VSD tracks people from only eight states and looks at a smaller percentage of low-income and minority people than is in the U.S. population as a whole. Moreover, VSD's usefulness depends on the continuing involvement of participating health plans. The U.S. Department of Health and Human Services and its partners should maintain their commitment to funding VSD and consider bringing in additional health plan members to enhance the data and make it more representative of the full U.S. population, the report says.

Newer data collection and surveillance systems offer great potential to monitor rare adverse events that may be associated with the childhood immunization schedule, the committee said. When fully implemented, the Sentinel Initiative program being developed by the U.S. Food and Drug Administration to monitor the safety of approved drugs and other medical products will complement existing passive vaccine surveillance systems, the report says. FDA's new Post-License Rapid Immunization Safety Monitoring Program is amassing a large amount of health data, offering the potential to analyze vaccine exposures and adverse events with a greater degree of statistical power.

Although randomized controlled trials are the gold standard for clinical research, such a trial cannot be safely and efficiently performed to compare health outcomes among vaccinated and unvaccinated or differently immunized children, the committee concluded. Among other reasons, children placed in the study group that does not receive vaccines in a timely fashion would be exposed to greater risk for contracting illnesses. Many parents who refuse immunization may object to their children being randomly assigned to the group that gets vaccines.

Some people have suggested comparing vaccinated children with children in "naturally occurring" populations of unimmunized individuals, such as certain religious communities. With less than 1 percent of the American population refusing all immunizations, however, it would be very difficult to recruit enough willing unvaccinated participants, the committee concluded. It can take tens of thousands of study participants to discover uncommon health problems. Moreover, these populations tend to be much less diverse ethnically, racially, socio-economically, and genetically than the general population, and because such factors can influence health, it would be difficult to determine if differences between the study groups are the result of vaccines or these other factors. The costs of conducting this kind of study or a randomized controlled trial likely would be prohibitive.

### The report was sponsored by the U.S. Department of Health and Human Services. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides objective, evidence-based advice to policymakers, health professionals, the private sector, and the public. The Institute of Medicine, National Academy of Sciences, National Academy of Engineering, and National Research Council together make up the private, nonprofit National Academies. For more information, visit http://national-academies.org or http://iom.edu. A committee roster follows.

Contacts: Christine Stencel, Senior Media Relations Officer Luwam Yeibio, Media Relations Assistant
Office of News and Public Information
202-334-2138; e-mail news@nas.edu

Additional resources: Report in Brief Project Website

Pre-publication copies of The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies are available from the National Academies Press on the Internet at http://www.nap.edu or by calling tel. 202-334-3313 or 1-800-624-6242. More information is available at http://www.iom.edu/childimmunizationschedule. Reporters may obtain a copy from the Office of News and Public Information (contacts listed above).

INSTITUTE OF MEDICINE Board on Population Health and Public Health Practice

Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule

Ada Sue Hinshaw, R.N., Ph.D. (chair)
Dean and Professor
Graduate School of Nursing
Uniformed Services University of the Health Sciences
Bethesda, Md.

Tomás Aragón, M.D., Dr.PH
Executive Director
Center for Infectious Disease Preparedness
School of Public Health
University of California
Berkeley

Alfred O. Berg, M.D., M.P.H.
Professor
Department of Family Medicine
School of Medicine
University of Washington
Seattle

Stephen L. Buka, M.A., M.S., Sc.D.
Professor and Head
Epidemiology Section
Department of Community Health
Brown University
Providence, R.I.

Gerry Fairbrother, Ph.D.
Senior Fellow
AcademyHealth
Washington, D.C.

Elena Fuentes-Afflick, M.D., M.P.H.
Professor of Pediatrics, Epidemiology, and Biostatistics
University of California, and
Chief of Pediatrics
San Francisco General Hospital
San Francisco

Sidney Gospe, Ph.D., M.D.
Herman and Faye Sarkowsky Endowed Chair; and
Professor and Head
Division of Pediatric Neurology
University of Washington
Seattle

Paul A. Greenberger, M.D.
Professor
Interdepartmental Immunobiology Center
Feinberg School of Medicine
Northwestern University
Chicago

Daniel F. Heitjan, Ph.D.
Professor of Biostatistics and Statistics
Department of Biostatistics and Epidemiology
School of Medicine
University of Pennsylvania
Philadelphia

Annette C. Leland, M.B.A.
Independent Consultant
Washington, D.C.

Pejman Rohani, Ph.D.
Professor
Department of Ecology and Evolutionary Biology
Center for the Study of Complex Systems
University of Michigan
Ann Arbor

Lainie Friedman Ross, M.D., Ph.D.
Carolyn and Matthew Bucksbaum Professor, and
Associate Director
MacLean Center for Clinical Medical Ethics
University of Chicago Chicago


Pauline A. Thomas, M.D.
Associate Professor
Department of Preventive Medicine and Community Health
New Jersey Medical School
Newark

STAFF

Karen Helsing, M.H.S.
Study Director


ELSE PRESS RELEASES FROM THIS DATE:

Robot allows 'remote presence' in programming brain and spine stimulators

2013-01-16
Philadelphia, Pa. (January 16, 2013) – With the rapidly expanding use of brain and spinal cord stimulation therapy (neuromodulation), new "remote presence" technologies may help to meet the demand for experts to perform stimulator programming, reports a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The preliminary study by Dr. Ivar Mendez of Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia, Canada, supports ...

Breast Cancer Message Board study finds frequent discussion of drug side effects, stopping therapy

2013-01-16
PHILADELPHIA -- In the first study to examine discussion of drug side effects on Internet message boards, researchers from the Perelman School of Medicine at the University of Pennsylvania found that breast cancer survivors taking the commonly prescribed adjuvant therapy known as aromatase inhibitors (AIs) often detailed in these forums troublesome symptoms resulting from the drugs, and they were apt to report discontinuing the treatment or switching to a different drug in the same class. The findings are published online this week in the journal Pharmacoepidemiology and ...

Sustainable reinforcement for concrete has newly discovered benefits

2013-01-16
Fashionable people may turn up their noses at jute — the cheap fiber used to make burlap, gunny sacks, twine and other common products — but new research is enhancing jute's appeal as an inexpensive, sustainable reinforcement for mortar and concrete. The study appears in ACS' journal Industrial & Engineering Chemistry Research. Subhasish B Majumder and colleagues note that there has been a resurgence of interest in using economical, sustainable natural fibers, rather than steel or synthetic fibers, to reinforce the cement compositions used to make concrete and mortar, ...

Development of the first way to make large amounts of promising anti-cancer substance

2013-01-16
Scientists are reporting development of the first practical way to make large amounts of a promising new anti-cancer substance that kills cancer cells differently than existing medicines. Their article on synthesis of the substance, and tests demonstrating its effectiveness in the laboratory, appears in ACS' Journal of Medicinal Chemistry. Isamu Shiina and colleagues explain that the substance, AMF-26, showed promise against certain forms of cancer in laboratory studies, fostering excitement about its potential for development as a new anti-cancer drug. That excitement ...

Attempts to correct 'death panel' myth may backfire

2013-01-16
Philadelphia, Pa. (January 16, 2012) – Efforts to correct false beliefs about health care reform may backfire, depending on individuals' political views and level of knowledge, suggests a study in the February issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. In the study, more politically knowledgeable people with positive views of Sarah Palin were likely to harden their opposition to the Affordable Care Act (ACA) when presented with information debunking Palin's "death panel" claim, according to the study ...

New biomarker may help in detecting gliomas, reports Neurosurgery

2013-01-16
Philadelphia, Pa. (January 16, 2013) – Researchers using sophisticated genetic testing techniques have identified a promising new biomarker for diagnosis of glioma—the most common type of malignant brain tumor, reports the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The biomarker ELTD1 "may serve as an additional biomarker for gliomas in preclinical and clinical diagnosis of gliomas," according to the study by Rheal A. Towner of Oklahoma ...

Promising new finding for therapies to treat persistent seizures in epileptic patients

Promising new finding for therapies to  treat persistent seizures in epileptic patients
2013-01-16
LOS ANGELES (Jan. 16, 2013) – In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain. "Despite the development of new medications to prevent seizures, status epilepticus remains a life-threatening condition that can cause extensive brain damage in the patients ...

Using snail teeth to improve solar cells and batteries

2013-01-16
RIVERSIDE, Calif. (www.ucr.edu) — An assistant professor at the University of California, Riverside's Bourns College of Engineering is using the teeth of a marine snail found off the coast of California to create less costly and more efficient nanoscale materials to improve solar cells and lithium-ion batteries. The most recent findings by David Kisailus, an assistant professor of chemical and environmental engineering, details how the teeth of chiton grow. The paper was published today (Jan. 16) in the journal Advanced Functional Materials. It was co-authored by several ...

Developed new method to diagnose hereditary breast and ovarian cancer

2013-01-16
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective. The new protocol has been described in an article published in the European Journal of Human Genetics. In recent years, new advances in sequencing techniques have involved the development of new platforms for nucleic ...

Dynamic Motivational Author, Speaker & Veteran Deborah L. Parker Keynotes Leesburg Virginia's Martin Luther King March & Program, "Moving the Dream Forward For All of Us" January 21

2013-01-16
Deborah L. Parker remembers the evening of April 4, 1968. In her rural Waverly Virginia home with no indoor plumbing, on the way to the laundromat with her mother, it seemed as if the world stopped. The headline of the evening news: Dr. Martin Luther King Jr. has been assassinated. What happens to the dream? Deborah wondered. She was poor, black, and a good student in a segregated Sussex County. Her mother was a single parent of four and they lived with her maternal grandparents in a shotgun style house on a wooded back road. But her mother was determined and her grandparents ...

LAST 30 PRESS RELEASES:

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

Technology for oxidizing atmospheric methane won’t help the climate

US Department of Energy announces Early Career Research Program for FY 2025

PECASE winners: 3 UVA engineering professors receive presidential early career awards

‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions

MSU researcher’s breakthrough model sheds light on solar storms and space weather

Nebraska psychology professor recognized with Presidential Early Career Award

New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration

Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins

From lab to field: CABBI pipeline delivers oil-rich sorghum

Stem cell therapy jumpstarts brain recovery after stroke

Polymer editing can upcycle waste into higher-performance plastics

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

Growth of private equity and hospital consolidation in primary care and price implications

Online advertising of compounded glucagon-like peptide-1 receptor agonists

[Press-News.org] IOM report details strategy for monitoring safety of childhood immunization schedule